| Identification | Back Directory | [Name]
4,7,10,13,16,19-Docosahexaenoic acid, (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (4Z,7Z,10Z,13Z,16Z,19Z)- | [CAS]
96998-00-4 | [Synonyms]
1-Palmitoyl-2-Docosahexaenoyl-sn-glycero-3-PE
1-Palmitoyl-2-Docosahexenoyl-sn-Glycero-3-Phosphatidylethanolamine
4,7,10,13,16,19-Docosahexaenoic acid, (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester, (4Z,7Z,10Z,13Z,16Z,19Z)- | [Molecular Formula]
C43H74NO8P | [MOL File]
96998-00-4.mol | [Molecular Weight]
764.02 |
| Chemical Properties | Back Directory | [Boiling point ]
775.3±70.0 °C(Predicted) | [density ]
1.024±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C | [solubility ]
Chloroform: 10 mg/ml | [form ]
liquid | [pka]
1.17±0.50(Predicted) |
| Hazard Information | Back Directory | [Uses]
1-?Palmitoyl-?2-?docosahexaenoyl-?sn-?glycero-?3-?phosphoethanolamine is used in the mRNA combination therapy for treatment of cancer. | [Definition]
ChEBI: 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine zwitterion is a phosphatidylethanolamine 38:6 zwitterion in which the acyl substituents at positions 1 and 2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively. It is a tautomer of a 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine. |
|
| Company Name: |
|
| Tel: |
4008-099-669 |
| Website: |
http://m.is0513.com/ShowSupplierProductsList112975/0.htm |
| Company Name: |
Creative Enzymes
|
| Tel: |
1-516-855-7709 |
| Website: |
www.creative-enzymes.com |
|